GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug QLS5316 enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called QLS5316 in about 300 adults with advanced solid tumors (including colorectal, stomach, head and neck, and lung cancers) that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the best…
Matched conditions: GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
New pill combo could slow stomach cancer progression
Disease control Not yet recruitingThis study tests whether taking two oral drugs—paclitaxel solution and fruquintinib—can help people with advanced stomach or gastroesophageal junction cancer live longer without their disease getting worse. It is for patients whose cancer did not respond to or caused side effects…
Matched conditions: GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC